hydrazine and al 8810
hydrazine has been researched along with al 8810 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Allemann, R; Flammer, J; Haefliger, IO; Vysniauskiene, I | 1 |
| Adner, M; Al-Ameri, M; Bergman, P; Bood, J; Dahlén, SE; Delin, I; Manson, ML; Orre, AC; Säfholm, J | 1 |
Other Studies
2 other study(ies) available for hydrazine and al 8810
| Article | Year |
|---|---|
Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Ciliary Arteries; Cloprostenol; Dinoprost; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; Latanoprost; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Swine; Travoprost; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Asthma; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Bronchi; Bronchoconstriction; Cells, Cultured; Dinoprost; Dinoprostone; Fatty Acids, Unsaturated; Histamine; Humans; Hydrazines; Immunoglobulin E; In Vitro Techniques; Mast Cells; Molecular Targeted Therapy; Naphthalenes; Phenylbutyrates; Prostaglandin D2; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Receptors, Thromboxane | 2015 |